148 related articles for article (PubMed ID: 3011712)
1. Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).
Byhardt RW; Hartz A; Libnoch JA; Hansen R; Cox JD
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):771-7. PubMed ID: 3011712
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
3. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and prognostic staging system for small cell lung cancer.
Kawahara M; Fukuoka M; Saijo N; Nishiwaki Y; Ikegami H; Tamura T; Shimoyama M; Suemasu K; Furuse K
Jpn J Clin Oncol; 1997 Jun; 27(3):158-65. PubMed ID: 9255270
[TBL] [Abstract][Full Text] [Related]
6. Small-cell carcinoma of the lung: derivation of a prognostic staging system.
Sagman U; Maki E; Evans WK; Warr D; Shepherd FA; Sculier JP; Haddad R; Payne D; Pringle JF; Yeoh JL
J Clin Oncol; 1991 Sep; 9(9):1639-49. PubMed ID: 1651996
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma.
Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
J Cancer Res Clin Oncol; 1998; 124(3-4):215-9. PubMed ID: 9619749
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis.
Hermes A; Gatzemeier U; Waschki B; Reck M
Respir Med; 2010 Dec; 104(12):1937-42. PubMed ID: 20719490
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment serum LDH as additional staging parameter in small-cell lung carcinoma.
Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Neth J Med; 1998 Feb; 52(2):65-70. PubMed ID: 9557528
[TBL] [Abstract][Full Text] [Related]
10. Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers.
Gronowitz JS; Steinholtz L; Källander CF; Hagberg H; Bergh J
Cancer; 1986 Jul; 58(1):111-8. PubMed ID: 3011236
[TBL] [Abstract][Full Text] [Related]
11. Lactate dehydrogenase values and bone scans as predictors of bone marrow involvement in small-cell lung cancer.
Hamrick RM; Murgo AJ
Arch Intern Med; 1987 Jun; 147(6):1070-1. PubMed ID: 3036032
[TBL] [Abstract][Full Text] [Related]
12. The impact of dose intensity of standard chemotherapy regimens in extensive stage small cell lung cancer.
Sheehan RG; Balaban EP; Frenkel EP
Am J Clin Oncol; 1993 Jun; 16(3):250-5. PubMed ID: 8393273
[TBL] [Abstract][Full Text] [Related]
13. Influence of age on the treatment of limited-stage small-cell lung cancer.
Siu LL; Shepherd FA; Murray N; Feld R; Pater J; Zee B
J Clin Oncol; 1996 Mar; 14(3):821-8. PubMed ID: 8622030
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in unresectable lung cancer].
Urata A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.
Spiegelman D; Maurer LH; Ware JH; Perry MC; Chahinian AP; Comis R; Eaton W; Zimmer B; Green M
J Clin Oncol; 1989 Mar; 7(3):344-54. PubMed ID: 2537384
[TBL] [Abstract][Full Text] [Related]
16. The highest prognostic impact of LDH among International Prognostic Indices (IPIs): an explorative study of five IPI factors among patients with DLBCL in the era of rituximab.
Park JH; Yoon DH; Kim DY; Kim S; Seo S; Jeong Y; Lee SW; Park CS; Huh J; Suh C
Ann Hematol; 2014 Oct; 93(10):1755-64. PubMed ID: 25027115
[TBL] [Abstract][Full Text] [Related]
17. Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.
Feld R; Evans WK; DeBoer G; Quirt IC; Shepherd FA; Yeoh JL; Pringle JF; Payne DG; Herman JG; Chamberlain D
J Clin Oncol; 1984 Apr; 2(4):294-304. PubMed ID: 6323640
[TBL] [Abstract][Full Text] [Related]
18. The role of surgery in small cell carcinoma of the lung (SCLC).
Holmes EC
Lung Cancer; 1995 Jun; 12 Suppl 3():S17-21. PubMed ID: 7551953
[No Abstract] [Full Text] [Related]
19. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy.
Quoix E; Purohit A; Faller-Beau M; Moreau L; Oster JP; Pauli G
Lung Cancer; 2000 Nov; 30(2):127-34. PubMed ID: 11086206
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]